- Tytuł:
- Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience
- Autorzy:
- Źródło:
- In Clinical Breast Cancer February 2023 23(2):155-161
Czasopismo naukowe